Tirzepatide has a slightly shorter half-life than semaglutide, approximately 5 days compared to 7 days
Readers should not rely on the content of this article as a basis for making any health-related decisions without consulting a licensed healthcare provider
La activacin adicional del receptor GIP regula el balance energtico y mejora el control glucmico por una va complementaria, lo que ha generado gran inters en investigacin sobre diabetes tipo 2, resistencia a la insulina y sndrome metablico
Energy availability for training, muscle preservation during caloric deficit, and recovery capacity all deserve attention during the switching period
Research suggests only 46% of patients continue to take a GLP-1 drug after 180 days, 29% at one year, and just 15% at two years.14 15 Similarly, their side effects include the loss of muscle mass,16 malnutrition resulting from strong appetite suppression, and increased risk of gallbladder disease.17 T2